Ma-Pi 2 macrobiotic diet and type 2 diabetes mellitus: Pooled analysis of short-term intervention studies

Diabetes/Metabolism Research and Reviews

Volumn 30, Issue S1, 2014, Pages 55-66

  Porrata Maury, C ^a   Hernandez Triana M ^b   Ruiz Alvarez V ^b   Diaz Sanchez M E ^b   Fallucca, F ^c   Bin, W ^d   Baba Abubakari, B ^e   Pianesi, M ^f  

^a FINLAY INSTITUTE   (Cuba)

^b Lipid Metabolism Laboratory   (Cuba)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Traditional Chinese Medicine Hospital   (China)

^e Tamale Teaching Hospital   (Ghana)

^f International Association Un Punto Macrobiotico   (Italy)

Author keywords

Adults; Ma Pi 2 macrobiotic diet; Type 2 diabetes; Vegetarian diets; Whole grain cereals

Indexed keywords

ADULTS; MA-PI 2 MACROBIOTIC DIET; TYPE 2 DIABETES; VEGETARIAN DIETS; WHOLE-GRAIN CEREALS;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHINA; CUBA; DIABETES MELLITUS, TYPE 2; DIET, MACROBIOTIC; DIETARY CARBOHYDRATES; DIETARY FATS; GHANA; HUMANS; ITALY; LIPIDS; RISK FACTORS;

EID: 84893906490     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2519     Document Type: Review

References (93)

1. Lauro R, Nicolucci A. Public health and health policy "an informed health policy on Chronic diseases". Facts and figures about the diabetes in Italy. 2011, Consorzio Mario Negri Sud.
2. Brown A, Desai M, Taneja D, Tannock LR. Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management. Postgrad Med 2010; 122(1): 163-171.
3. American Diabetes Association (ADA). Standard of Medical Care in Diabetes-2013. Position Statement of the American Diabetes Association. Diabetes Care 2013; 36(Supplement1): S11-S66.
4. Associazione Medici Diabetologi (AMD). Standard italiani per la cura del diabete mellito tipo 2. Edizione per la Medicina Generale. Editore Infomedica, Edizione 2011.
5. Jenkins DJ, Kendall CW, Marchie A, et al. Type 2 diabetes and the vegetarian diet. Am J Clin Nutr 2003; 78: 610S-616S.
6. Barnard ND, Cohen J, Jenkins DJ, et al. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care 2006; 29(8): 1777-1783.
7. Trapp C, Barnard N, Katcher H. A plant-based diet type 2 diabetes: scientific support and practical strategies. Diabetes Educ 2010; 36(1): 33-48.
8. Farmer B, Larson BT, Fulgoni V III, Rainville AJ, Liepa GU. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the National Health and Nutrition Examination Survey 1999-2004. J Am Diet Assoc 2011; 111: 819-827.
9. Craig WJ, Mangels AR. American Dietetic Association. Position of the American Dietetic Association. Vegetarian Diets. J Am Diet Assoc 2009; 109(7): 1266-1282.
10. Wylie-Rosett J, Segal-Isaacson CJ, Segal-Isaacson A. Carbohydrates and increases in obesity: does the type of carbohydrate make a difference? Obes Res 2004; 12(Suppl 2): 124S-129S.
11. Colditz GA, Manson JE, Stampfer FE, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in woman. Am J Clin Nutr 1992; 55: 1018-1023.
12. Willett W, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr 2002; 76(1): 274S-280S.
13. Wolk A, Manson JE, Stampfer MJ, et al. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 1999; 281(21): 1998-2004.
14. Schulze MB, Liu S, Rimm EB, Manson JE, Willett WC, Hu FB. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr 2004; 80(2): 348-356.
15. Stevens J, Ahn K, Juhaeri, Houston D, Steffan L, Couper D. Dietary fiber intake and glycemic index and incidence of diabetes in African-American and white adults: the ARIC study. Diabetes Care 2002; 25(10): 1715-1721.
16. Liese AD, Roach AK, Sparks KC, Marquart L, D'Agostino RB Jr, Mayer-Davis EJ. Whole-grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr 2003; 78(5): 965-971.
17. Kendall CW, Emam A, Augustin LS, Jenkins DJ. Resistant starches and health. J AOAC Int 2004; 87(3): 769-774.
18. Mc Keown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole grain intake is favourable associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham off Spring Study. Am J Clin Nutr 2002; 76: 390-398.
19. Jenkins DJ, Kendall CW, Augustin LS, et al. Effect of wheat bran on glycaemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care 2002; 25: 1522-1528.
20. Beylot M. Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 2005; 93(Suppl 1): S163-S168.
21. Losada MA, Olleros T. Towards a healthier diet for the colon: the influence of fructooligosaccharides and lactobacilli on intestinal health. Nutr Res 2002; 22: 71-84.
22. Mooren FC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects-a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab 2011; 13(3): 281-284.
23. Kim DJ, Xun P, Liu K, et al. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010; 33(12): 2604-2610.
24. Nakanishi S, Yamane K, Ohishi W, et al. Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans. Diabetes Res Clin Pract 2008; 81(3): 381-385.
25. Rungby J. Zinc, zinc transporters and diabetes. Diabetologia 2010; 53(8): 1549-1551.
26. Liu Q, Yao H. Antioxidant activities of barley seeds extracts. Food Chem 2007; 102(3): 732-737.
27. Fardet A, Rock E, Remesy C. Is the in vitro antioxidant potential of whole-grain cereals and cereal products well reflected in vivo? J Cereal Sci 2008; 48: 258-276.
28. Baliarsingh S, Beg ZH, Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 2005; 182(2): 367-374.
29. Sen CK, Khanna S, Roy S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med 2007; 28(5-6): 692-728.
30. Granfeldt Y, Wu X, Bjorck I. Determination of glycaemic index; some methodological aspects related to the analysis of carbohydrate load and characteristics of the previous evening meal. Eur J Clin Nutr 2006; 60(1): 104-112.
31. Nilsson A, Ostman E, Preston T, Bjorck I. Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. Eur J Clin Nutr 2008; 62(6): 712-720.
32. Stevenson E, Williams C, Nute M, Humphrey L, Witard O. Influence of the glycaemic index of an evening meal on substrate oxidation following breakfast and during exercise the next day in healthy women. Eur J Clin Nutr 2008; 62(5): 608-616.
33. Brighenti F, Benini L, Del Rio D, et al. Colonic fermentation of indigestible carbohydrates contributes to the second-meal effects. Am J Clin Nutr 2006; 83(4): 817-822.
34. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005; 82: 559-567.
35. Robertson MD. Metabolic cross talk between the colon and the periphery: implications for insulin syndrome. Proc Nutr Soc 2007; 66(3): 351-361.
36. Galisteo M, Duarte J, Zarzuelo A. Effects of dietary fibers on disturbance clustered in the metabolic syndrome. J Nutr Biochem 2008; 19: 71-84.
37. Priebe MG, Wang H, Weening D, Schepers M, Preston T, Vonk RJ. Factors related to colonic fermentation of nondigestible carbohydrates of a previous evening meal increase tissue glucose uptake and moderate glucose-associated inflammation. Am J Clin Nutr 2010; 91(1): 90-97.
38. Nilsson AC, Ostman EM, Holst JJ, Bjorck IM. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr 2008; 138(4): 732-739.
39. Segain JP, Raingeard de la Blétière D, Bourreille A, et al. Butyrate inhibits inflammatory response through NFkappaB inhibition: implications for Crohn's disease. Gut 2000; 47(3): 397-403.
40. Sun Q, Spiegelman D, van Dam RM, et al. White rice, brown rice, and risk of type 2 diabetes in US men and women. Arch Intern Med 2010; 170(11): 961-969.
41. Pathak P, Srivastava S, Grover S. Development of food products based on millet, legumes and fenugreek seeds and their suitability in the diabetic diet. Int J Food Sci Nutr 2000; 51(5): 409-414.
42. Feldman N, Norenberg C, Voet H, Manor E, Berner Y, Madar Z. Enrichment of an Israeli ethnic food with fibres and their effects on the glycaemic and insulinaemic responses in subjects with non-insulin dependent diabetes mellitus. Br J Nutr 1995; 74(5): 681-688.
43. Abdelgadir M, Abbast M, Jarvi A, Elbagir M, Eltom M, Berne C. Glycaemic and insulin responses of six traditional Sudanese carbohydrate-rich meals in subjects with Type 2 diabetes mellitus. Diabet Med 2005; 22(2): 213-217.
44. Nishizawa N, Togawa T, Park KO, et al. Dietary Japanese millet protein ameliorates plasma levels of adinopectin, glucose, and lipids in type 2 diabetic mice. Biosci Biotechnol Biochem 2009; 73(2): 351-360.
45. Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997; 20(4): 545-550.
46. Priebe MG, van Binsbergen JJ, de Vos R, Vonk RJ. Whole grain foods for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 2008; CD006061.
47. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444(7121): 840-846.
48. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988; 66(1): 140-146.
49. Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007; 2(5): 883-888.
50. Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 2006; 17(5): 1422-1428.
51. Adeva MM, Souto G. Diet-induced metabolic acidosis. Clin Nutr 2011; 30(4): 416-421.
52. Farwell WR, Taylor EN. Serum bicarbonate, anion gap and insulin resistance in the National Health and Nutrition Examination Survey. Diabet Med 2008; 25(7): 798-804.
53. Souto G, Donapetry C, Calviño J, Adeva MM. Metabolic acidosis-induced insulin resistance and cardiovascular risk. Metab Syndr Relat Disord 2011; 9(4): 247-253.
54. Kontessis P, Jones S, Dodds R, et al. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 1990; 38(1): 136-144.
55. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardio renal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 2008; 31(4): 648-654.
56. DeFronzo RA, Beckles AD. Glucose intolerance following chronic metabolic acidosis in man. Am J Physiol 1979; 236(4): E328-E334.
57. Cunningham-Rundles S, McNeeley DF, Moon A. Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol 2005; 115(6): 1119-1128.
58. Porrata C, Hernández M, Abuín A, Campa C, Pianesi M. Caracterización y evaluación nutricional de las dietas macrobióticas Ma-Pi. Rev Cubana Investig Bioméd 2008; 27(3-4): 1-36.
59. Bhumisawasdi J, Vanna O, Surinpang N. The self-reliant system for alternative care of diabetes mellitus patients. Experience macrobiotic management in Trad Province. J Med Assoc Thai 2006; 89(12): 2104-2115.
60. Porrata C, Abuín A, Morales A, et al. Efecto terapéutico de la dieta macrobiótica Ma-Pi 2 en 25 adultos con diabetes mellitus tipo 2. Rev Cubana Invest Biomed 2007; 26(2).
61. Porrata C, Sánchez J, Correa V, et al. Ma-Pi 2 macrobiotic diet intervention in adults with type 2 diabetes mellitus. MEDICC Rev 2009; 11(4): 29-34.
62. Kablan BJ, Kouassi D, N'Guetta KF, et al. Curative effects of Ma-Pi 2 macrobiotic diet in Ivorian type 2 diabetic. Cahier de Santé Publique 2011; 10(2): 97-125.
63. Yapo RM, Adoueni VK, Ehouman G, Porrata Maury C, Pianesi M. Ma-Pi 2 Macrobiotic Diet intervention during six months in adults with type 2 diabetes mellitus, Cote d'Ivoire, 2010. Revue Soc Sci Nat de Tunisie 2010-2011; 37: 62-71.
64. Porrata C, Hernández M, Rodríguez E, et al. Medium-and short-term interventions with Ma-Pi 2 macrobiotic diet in type 2 diabetic adults of Bauta, Havana. J Nutr Metab 2012; 2012: Article ID 856342, doi:10.1155/2012/856342.
65. Bin W, Porrata C, Weiguo M, et al. Short term effect of the Ma-Pi 2 macrobiotic diet in type 2 diabetic adults of Beijing. Latin American Nutrition Congress, Nov 12-16, 2012. ISBN: 978-959-7003-41-0
66. Abubakari BB, Sagoe K, Mutawakilu I, et al. Ma-Pi 2 macrobiotic diet intervention during 21 days in adults with type 2 diabetes mellitus, Ghana, 2011. Latin American Nutrition Congress, Nov 12-16, 2012. ISBN: 978-959-7003-41-0
67. Fallucca F, Porrata C, Monaco G, Bufacchi A, Pianesi M. Ma-Pi Macrobiotic Diet Intervention during 21 days in adult with type 2 diabetes mellitus, Rome 2012. 7° World Congress on Preventing Diabetes and its complications, Nov 11-14, 2012. Minerva Endocrinol 2012; 37(suppl. 4): 116.
68. th April 2013] Available from: http://www.upcomillas.es/personal/peter/investigacion/Tama%F1oDelEfecto.pdf.
69. Rosenthal JA. Qualitative descriptors of strength of association and effect size. J Soc Serv Res 1996; 21(4): 37-59.
70. Zanuso S, Jimenez A, Pugliese G, Corigliano G, Balducci S. Exercise for the management of type 2 diabetes: a review of the evidence. Acta Diabetol 2010; 47: 15-22.
71. Balducci C, Zanuso S, Nicolucci A, et al. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). Arch Intern Med 2010; 170(20): 1794-1803.
72. Nicolucci A, Balducci S, Cardelli P, et al. Relationship of exercise volume to improvements of quality of life with supervised exercise training in patients with type 2 diabetes in a randomised controlled trial: the Italian Diabetes and Exercise Study (IDES). Diabetologia 2012; 55: 579-588.
73. Nicolucci A, Balducci S, Cardelli P, Zanuso S, Pugliese G. Supervised exercise training improves quality of life in subjects with type 2 diabetes. Arch Intern Med 2011; 171: 1951-1953.
74. Dunstan DW, Daly RM, Owen N, Jolley D, et al. High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care 2002; 25: 1729-1736.
75. Klein S, Sheard NF, Pi-Sunter X, et al. American Diabetes Association; North American Association for the Study of Obesity; American Society for Clinical Nutrition. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. Diabetes Care 2004; 27: 2067-2073.
76. Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Eng J Med 2002; 347: 1342-1349.
77. Sheehan MT. Current therapeutic options in type 2 diabetes mellitus: a practical approach. Clin Med Res 2003; 1: 189-200.
78. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87(1): 4-14.
79. Connor H, Annan F, Bunn E, et al. The implementation of nutritional advice for people with diabetes. Diabet Med 2003; 20(10): 786-807.
80. Wheeler ML, Dunbar SA, Jaacks LM, et al. Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010. Diabetes Care 2012; 35: 434-445.
81. Stern L, Iqbal N, Seshadri P, et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one year follow-up of a randomized trial. Ann Intern Med 2004; 140: 778-785.
82. Esposito K, Maiorino MI, Ciotola M, et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med 2009; 151: 306-314.
83. Turner-McGrievy GM, Barnard ND, Cohen J, Jenkins DJ, Gloede L, Green AA. Changes in nutrient intake and dietary quality among participants with type 2 diabetes following a low-fat vegan diet for 22weeks. J Am Diet Assoc 2008; 108: 1636-1645.
84. González Montesino D. Capacidad antioxidante y aporte de polifenoles de la dieta macrobiótica implementada en el Instituto Finlay. Tesis presentada en opción al título Académico de Master en Ciencias y Tecnología de los Alimentos. Facultad de Farmacia y Alimentos. Universidad de la Habana, Junio, 2009.
85. Saura-Calixto F, Goñi I. Antioxidant capacity of the Spanish Mediterranean diet. Food Chem 2006; 94(3): 442-447.
86. Delzenne NM, Cani PD. Gut microbiota and the pathogenesis of insulin resistance. Curr Diab Rep 2011; 11(3): 154-159.
87. Lee JY, Zhao L, Hwang DH. Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids. Nutr Rev 2010; 68(1): 38-61.
88. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5(2): e9085.
89. Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 2011; 12(4): 272-281.
90. Oozeer R, Rescigno M, Ross RP, et al. Gut health: predictive biomarkers for preventive medicine and development of functional foods. Br J Nutr 2010; 103(10): 1539-1544.
91. Kootte RS, Vrieze A, Holleman F, et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2012; 14(2): 112-120.
92. Igarashi K, Honma K, Yoshinari O, Nanjo F, Hara Y. Effects of dietary catechins on glucose tolerance, blood pressure and oxidative status in Goto-Kakizaki rats. J Nutr Sci Vitaminol 2007; 53(6): 496-500.
93. Gomikawa S, Ishikawa Y, Hayase W, et al. Effect of ground green tea drinking for 2weeks on the susceptibility of plasma and LDL to the oxidation ex vivo in healthy volunteers. Kobe J Med Sci 2008; 54(1): E62-E72.